ImmunoGen

IMGN

IMGN
ImmunoGen Stock Quote
$3.27 $0.05 1.6%
BATS BZX Real Time Price as of November 13, 2019, 4:00 p.m. EST View Interactive IMGN Charts

ImmunoGen develops cancer therapeutics through its tumor-activated, prodrug technology, which targets antibodies with cancer-killing drugs.

News & Analysis: ImmunoGen

The Fool has written over 200 articles on ImmunoGen.

All

Market Moves

Earnings







Interactive Chart